# Cabozantinib S-Malate (Cometriq)

Source: https://ourhealthnetwork.com/drugs/cabozantinib-s-malate
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Cabozantinib S-Malate?

Cabozantinib S-Malate (brand name: Cometriq) is a kinase inhibitor. It is prescribed to treat carcinoma, renal cell. Across the United States, 1,000 doctors prescribe Cabozantinib to approximately 802 Medicare patients.

## Brand names

Cometriq

## Indications

Cabozantinib S-Malate is prescribed for the treatment of carcinoma and renal cell.

## Conditions treated

- [Carcinoma](https://ourhealthnetwork.com/conditions/carcinoma)
- [Renal Cell](https://ourhealthnetwork.com/conditions/renal-cell)

## Mechanism of action

These receptor tyrosine kinases are involved in both normal cellular function and pathologic processes such as oncogenesis, metastasis, tumor angiogenesis, drug resistance, and maintenance of the tumor mi

## Drug classification

- Established Pharmacologic Class: kinase inhibitors
- Route of administration: ORAL

## Common side effects

decreased appetite, decreased weight, diarrhea, dysgeusia, fatigue, hair color changes, nausea, oral pain

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)